AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $29.56 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4 Good Index. For more information about AstraZeneca, please visit: www.astrazeneca.com.
Press Release Clinical Oncology Publishes Findings from First-Ever Initiative on Sustainable Breast Cancer Treatment in the Developing World
Press Release AstraZeneca Receives FDA Approval for Faslodex - A New Type of Breast Cancer Treatment
Report CSR Report 2001